{"hands_on_practices": [{"introduction": "To truly grasp the mechanisms of allorecognition, we begin with a foundational thought experiment. This exercise strips the system down to its essential components, focusing on the specific molecular interactions that define the direct and indirect pathways. By considering a hypothetical scenario where the T-cell receptor's recognition capabilities are precisely altered, you can solidify your understanding of what the recipient's T-cells \"see\" in each case, a critical first step in diagnosing and manipulating transplant rejection [@problem_id:2215661].", "problem": "In the context of solid organ transplantation, graft rejection is primarily mediated by the recipient's T cells recognizing foreign antigens from the donor. This process, known as allorecognition, occurs through different pathways. The cells of the donor's organ express a unique set of surface proteins called the Major Histocompatibility Complex (MHC).\n\nConsider a hypothetical clinical scenario involving a kidney transplant. The recipient has a rare and specific genetic defect. This defect alters the structure of all of their T Cell Receptors (TCRs) such that they are completely incapable of binding to any intact non-self MHC molecule on the surface of another cell. However, their TCRs retain their full and normal ability to bind to their own (self) MHC molecules when these molecules are presenting peptides.\n\nGiven this specific cellular defect in the recipient, which of the following immunological pathways would be completely abrogated?\n\nA. The direct pathway of allorecognition\n\nB. The indirect pathway of allorecognition\n\nC. Both the direct and indirect pathways of allorecognition\n\nD. Neither of the T cell allorecognition pathways would be affected", "solution": "Allorecognition by recipient T cells proceeds via:\n- Direct pathway: recipient T cells recognize intact donor MHC-peptide complexes presented on the surface of donor antigen-presenting cells. This pathway requires the recipient TCRs to bind non-self MHC molecules directly.\n- Indirect pathway: donor antigens, including donor MHC proteins, are processed by recipient antigen-presenting cells and presented as peptides on self MHC molecules. This pathway requires recipient TCRs to bind self MHC-peptide complexes.\n\nGiven the defect: the recipient’s TCRs are completely incapable of binding any intact non-self MHC on another cell but retain full ability to bind self MHC presenting peptides. Therefore:\n- Direct pathway is eliminated because it depends on TCR recognition of intact non-self MHC.\n- Indirect pathway remains intact because it depends on recognition of peptides presented by self MHC, which is preserved.\n\nThus, the pathway completely abrogated is the direct pathway of allorecognition.", "answer": "$$\\boxed{A}$$", "id": "2215661"}, {"introduction": "Moving from foundational concepts to experimental application, this practice challenges you to think like a research immunologist. Unraveling a complex biological process like the indirect pathway requires designing experiments that can isolate and test the role of individual mechanistic steps. Here, you are tasked with evaluating several experimental approaches to identify the most rigorous test for a specific hypothesis about antigen cross-presentation, a core skill for advancing our understanding of immunology [@problem_id:2215678].", "problem": "A researcher is investigating the immunological mechanisms underlying transplant rejection, focusing on the indirect pathway of allorecognition. In this pathway, Antigen-Presenting Cells (APCs) of the recipient internalize cellular material from the donor graft, process donor antigens, and present them on their own Major Histocompatibility Complex (MHC) molecules. For the activation of recipient cytotoxic CD8+ T-cells, which are critical for killing graft cells, this process requires that intact donor MHC class I molecules are first transported from the phagosome into the cytosol of the recipient APC. There, they are degraded by the proteasome, and the resulting peptides are loaded onto the recipient's MHC class I molecules for presentation to CD8+ T-cells (a process known as cross-presentation).\n\nThe central hypothesis is that this specific trafficking step—the escape of intact donor MHC class I proteins from the phagosome into the cytosol—is the primary rate-limiting step governing the kinetics of CD8+ T-cell activation via the indirect pathway.\n\nYou are provided with the following biological resources:\n- **Donor Mice:** Inbred strain BALB/c, expressing the MHC haplotype $H-2^d$. Let's denote their MHC class I molecule of interest as $K^d$.\n- **Recipient Mice:** Inbred strain C57BL/6, expressing the MHC haplotype $H-2^b$. Their relevant MHC class I molecule is $K^b$.\n- **Specialized T-cells:** A clone of CD8+ T-cells, isolated from a C57BL/6 mouse, which specifically recognizes a known peptide derived from the $K^d$ molecule, but only when this peptide is presented by the $K^b$ molecule. These T-cells will not activate if they encounter intact $K^d$ on donor cells.\n- **Assay Method:** An assay that can quantitatively measure the production of Interferon-gamma (IFN-$\\gamma$) by activated T-cells over time.\n\nWhich of the following experimental designs is the most specific and rigorous for testing the hypothesis that phagosomal escape is the rate-limiting step for the indirect activation of these specialized CD8+ T-cells?\n\nA. Engineer two versions of donor BALB/c cells. Group 1 expresses the normal $K^d$ molecule. Group 2 expresses a genetically engineered fusion protein consisting of the $K^d$ molecule linked to listeriolysin O (LLO), a pore-forming toxin known to disrupt phagosomal membranes. Culture C57BL/6 dendritic cells (as the recipient APCs) with irradiated, non-proliferating cells from either Group 1 or Group 2. After a short incubation, add the specialized CD8+ T-cells and measure the rate of IFN-$\\gamma$ production over a 48-hour period.\n\nB. Culture C57BL/6 dendritic cells with irradiated BALB/c splenocytes. Divide these co-cultures into two sets. Treat one set with chloroquine, a drug that raises the pH of endocytic vesicles and inhibits the function of lysosomal proteases. Treat the other set with a vehicle control. After a short pre-treatment, add the specialized CD8+ T-cells and measure total IFN-$\\gamma$ production after 48 hours.\n\nC. Culture C57BL/6 dendritic cells with irradiated BALB/c splenocytes. Divide these co-cultures into two sets. Treat one set with the proteasome inhibitor MG-132. Treat the other set with a vehicle control. After a short pre-treatment, add the specialized CD8+ T-cells and measure total IFN-$\\gamma$ production after 48 hours.\n\nD. Culture the specialized CD8+ T-cells directly with irradiated BALB/c splenocytes without any C57BL/6 dendritic cells. In parallel, culture the same T-cells with C57BL/6 dendritic cells that have been pulsed with the specific synthetic peptide derived from $K^d$. Compare the rate of IFN-$\\gamma$ production between the two cultures.\n\nE. Perform the experiment exactly as described in option A. However, instead of using the specialized CD8+ T-cells, use a polyclonal population of CD4+ T-cells isolated from a C57BL/6 mouse that was previously immunized with BALB/c cells. Measure the rate of T-cell proliferation over a 72-hour period.\n\nF. Culture C57BL/6 dendritic cells with irradiated BALB/c splenocytes. Divide these co-cultures into two sets. Treat one set with cytochalasin D, a potent inhibitor of actin polymerization which blocks phagocytosis. Treat the other set with a vehicle control. After a short pre-treatment, add the specialized CD8+ T-cells and measure total IFN-$\\gamma$ production after 48 hours.", "solution": "We formalize the indirect pathway of cross-presentation leading to CD8 T-cell activation as a sequence of necessary steps within a recipient dendritic cell (DC):\n1) uptake of donor material by phagocytosis,\n2) phagosomal escape of intact donor MHC class I proteins into the cytosol,\n3) proteasomal degradation to generate peptides,\n4) peptide transport into the endoplasmic reticulum via TAP,\n5) loading of peptide onto recipient MHC class I ($K^b$),\n6) surface presentation and T-cell activation culminating in IFN-$\\gamma$ secretion.\n\nLet the steps be sequential with effective first-order rate constants $\\{k_{\\text{upt}},k_{\\text{esc}},k_{\\text{prot}},k_{\\text{TAP}},k_{\\text{load}},k_{\\text{act}}\\}$. For series processes, the steady flux $J$ toward peptide-MHC presentation is constrained by the smallest effective rate constant. If $k_{\\text{esc}}$ is the smallest, then increasing $k_{\\text{esc}}$ should increase the kinetic rate of presentation and thus the rate of IFN-$\\gamma$ production $r_{\\gamma}(t)$, with $r_{\\gamma}(t)\\propto J(t)$. A rigorous and specific test of the hypothesis that phagosomal escape is rate-limiting must selectively increase $k_{\\text{esc}}$ while keeping other steps unchanged and measure kinetics (rate) rather than only endpoints.\n\nWe assess each option relative to selective modulation of $k_{\\text{esc}}$ and appropriate readout:\n- Option A directly targets the phagosomal escape step by expressing a $K^d$-LLO fusion in donor cells. Listeriolysin O promotes phagosomal membrane permeabilization; when donor material is phagocytosed by C57BL/6 DCs, increased phagosomal escape elevates $k_{\\text{esc}}$. The specialized CD8 T cells recognize a $K^d$-derived peptide presented on $K^b$, ensuring the readout reports cross-presentation and not direct allorecognition. Measuring the rate of IFN-$\\gamma$ production over time specifically tests whether increasing $k_{\\text{esc}}$ accelerates the kinetics, as predicted if $k_{\\text{esc}}$ is rate-limiting.\n- Option B modulates endosomal pH and lysosomal proteases with chloroquine, altering endosomal processing rather than the cytosolic escape step. This does not directly test whether $k_{\\text{esc}}$ is limiting and uses an endpoint measurement at a single time point.\n- Option C inhibits the proteasome (reducing $k_{\\text{prot}}$), which will suppress cross-presentation and confirm proteasome dependence but provides no specific information on whether $k_{\\text{esc}}$ was rate-limiting before inhibition; it also employs an endpoint measurement.\n- Option D compares direct allorecognition versus peptide-pulsed DC activation, serving as a control to validate T-cell specificity, but it does not manipulate or test the phagosomal escape step.\n- Option E substitutes CD8 T cells with polyclonal CD4 T cells and measures proliferation via MHC class II presentation; this addresses a different pathway and cannot test the CD8 cross-presentation escape step.\n- Option F blocks phagocytosis with cytochalasin D (reducing $k_{\\text{upt}}$), thereby reducing antigen input. While this shows uptake is required, it cannot identify whether the downstream escape step is rate-limiting; it also uses an endpoint measurement.\n\nTherefore, only Option A specifically increases $k_{\\text{esc}}$ and measures kinetic consequences on IFN-$\\gamma$ production by the precisely relevant CD8 T cells, making it the most specific and rigorous test of the stated hypothesis.", "answer": "$$\\boxed{A}$$", "id": "2215678"}, {"introduction": "The behavior of vast cell populations can often be described and predicted using mathematical models, a powerful approach in quantitative immunology. This exercise applies a classic population growth model to the dynamics of the direct allorecognition pathway, introducing a time-dependent carrying capacity, $K(t)$, to represent the finite lifespan of donor antigen-presenting cells. By solving for the peak of the T-cell response, you will quantitatively connect a known biological constraint—the transience of donor APCs—to the characteristic rise-and-fall kinetics of the direct pathway response [@problem_id:2831575].", "problem": "A cohort of Cluster of Differentiation 8 (CD8) T cells specific for donor Major Histocompatibility Complex (MHC) expands via the direct allorecognition pathway immediately after transplantation. In this pathway, donor antigen-presenting cells (APCs) directly stimulate recipient T cells but are rapidly lost from the graft-draining environment. Assume the following mechanistic base grounded in well-tested immunological and population-dynamical principles:\n\n- Clonal size $N(t)$ of the alloreactive CD8 T cells undergoes density-limited expansion with an intrinsic per capita growth rate $r>0$.\n- The maximal sustainable clonal size (effective carrying capacity) is proportional to the abundance of donor APCs that present intact donor MHC. Donor APC abundance decays as $\\exp(-\\alpha t)$ with $\\alpha>0$ due to emigration and apoptosis, so the carrying capacity declines as $K(t)=K \\exp(-\\alpha t)$, where $K>0$ is the notional capacity at $t=0$.\n- Early expansion under the direct pathway is well-described by a logistic growth law with a time-dependent carrying capacity:\n$$\n\\frac{dN}{dt} \\;=\\; r\\,N(t)\\left(1 - \\frac{N(t)}{K(t)}\\right) \\,,\n$$\nwith initial condition $N(0)=N_0$ satisfying $0<N_0<K$.\n\nDefine the peak of the clonal response as the first time $t_{\\text{peak}}$ at which net proliferation ceases under antigen limitation, namely the first $t>0$ such that $\\frac{dN}{dt}=0$ for the above dynamics. Using only the stated assumptions and model, derive a closed-form analytic expression for $t_{\\text{peak}}$ in terms of $r$, $K$, $\\alpha$, and $N_0$. Express the final time in days. No numerical substitution is required, and no rounding is requested. Your answer must be a single closed-form expression.", "solution": "The problem as stated is subjected to validation.\n\nGivens are extracted verbatim:\n1.  The differential equation for clonal size $N(t)$: $\\frac{dN}{dt} = r\\,N(t)\\left(1 - \\frac{N(t)}{K(t)}\\right)$.\n2.  Intrinsic per capita growth rate: $r>0$.\n3.  Time-dependent carrying capacity: $K(t)=K \\exp(-\\alpha t)$.\n4.  Initial carrying capacity constant: $K>0$.\n5.  Decay rate of carrying capacity: $\\alpha>0$.\n6.  Initial condition for clonal size: $N(0)=N_0$.\n7.  Constraint on initial condition: $0<N_0<K$.\n8.  Definition of peak response time, $t_{\\text{peak}}$: The first time $t>0$ such that $\\frac{dN}{dt}=0$.\n\nThe problem is validated as follows:\n-   **Scientific Grounding**: The model is based on the logistic equation, a fundamental principle in population dynamics, and its application to lymphocyte clonal expansion is a standard approach in mathematical immunology. The premise of a decaying carrying capacity due to the loss of donor antigen-presenting cells in the direct allorecognition pathway is immunologically sound.\n-   **Well-Posedness**: The problem provides a well-defined ordinary differential equation with an initial condition. The quantity to be derived, $t_{\\text{peak}}$, is unambiguously defined. The setup is self-contained and sufficient for deriving a unique analytical solution.\n-   **Objectivity**: The problem is formulated in precise, quantitative terms, free of subjective or ambiguous language.\n\nThe verdict is that the problem is valid. It is a formal, solvable problem in applied mathematics and theoretical biology. We proceed to the solution.\n\nThe objective is to find the time $t_{\\text{peak}}$, defined as the first time $t>0$ for which the net proliferation rate is zero. The governing equation is:\n$$\n\\frac{dN}{dt} = r N(t) \\left(1 - \\frac{N(t)}{K(t)}\\right)\n$$\nThe condition $\\frac{dN}{dt}=0$ implies either $N(t)=0$ or $1 - \\frac{N(t)}{K(t)} = 0$. Since the initial population $N_0$ is positive and the initial growth rate $\\frac{dN}{dt}\\Big|_{t=0} = r N_0 (1-N_0/K)$ is positive (because $r>0$, $N_0>0$, and $N_0<K$), the population $N(t)$ will increase from $N_0$ and will not be zero for $t>0$. Therefore, the peak condition must be:\n$$\n1 - \\frac{N(t_{\\text{peak}})}{K(t_{\\text{peak}})} = 0 \\quad \\implies \\quad N(t_{\\text{peak}}) = K(t_{\\text{peak}})\n$$\nThis means we must find the time at which the expanding T cell population size equals the decaying carrying capacity. To do this, we must first find the analytical solution $N(t)$.\n\nThe governing equation can be rewritten by substituting $K(t) = K \\exp(-\\alpha t)$:\n$$\n\\frac{dN}{dt} = rN - \\frac{rN^2}{K \\exp(-\\alpha t)}\n$$\nThis is a Bernoulli differential equation of the form $\\frac{dy}{dt} + P(t)y = Q(t)y^n$ with $n=2$. We rearrange it to the standard form:\n$$\n\\frac{dN}{dt} - rN = -\\frac{r}{K} \\exp(\\alpha t) N^2\n$$\nWe use the substitution $u(t) = N(t)^{1-2} = N(t)^{-1}$. The derivative is $\\frac{du}{dt} = -N^{-2}\\frac{dN}{dt}$. Multiplying the Bernoulli equation by $-N^{-2}$ gives:\n$$\n-N^{-2}\\frac{dN}{dt} + rN^{-1} = \\frac{r}{K} \\exp(\\alpha t)\n$$\nSubstituting $u$ and its derivative, we obtain a first-order linear differential equation:\n$$\n\\frac{du}{dt} + r u = \\frac{r}{K} \\exp(\\alpha t)\n$$\nWe solve this using an integrating factor $I(t) = \\exp\\left(\\int r \\, dt\\right) = \\exp(rt)$. Multiplying the linear equation by $I(t)$:\n$$\n\\exp(rt) \\frac{du}{dt} + r \\exp(rt) u = \\frac{r}{K} \\exp(\\alpha t) \\exp(rt)\n$$\nThe left side is the derivative of a product:\n$$\n\\frac{d}{dt} \\left(u(t) \\exp(rt)\\right) = \\frac{r}{K} \\exp\\left((\\alpha+r)t\\right)\n$$\nIntegrating both sides with respect to $t$:\n$$\nu(t) \\exp(rt) = \\int \\frac{r}{K} \\exp\\left((\\alpha+r)t\\right) dt = \\frac{r}{K(\\alpha+r)} \\exp\\left((\\alpha+r)t\\right) + C\n$$\nwhere $C$ is the constant of integration. We solve for $u(t)$:\n$$\nu(t) = \\frac{r}{K(\\alpha+r)} \\exp(\\alpha t) + C \\exp(-rt)\n$$\nTo determine $C$, we apply the initial condition $N(0)=N_0$, which implies $u(0) = 1/N_0$. At $t=0$:\n$$\n\\frac{1}{N_0} = \\frac{r}{K(\\alpha+r)} \\exp(0) + C \\exp(0) \\quad \\implies \\quad C = \\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}\n$$\nSubstituting $C$ back into the expression for $u(t)$ and recalling $u(t)=1/N(t)$, we have the solution for $1/N(t)$:\n$$\n\\frac{1}{N(t)} = \\frac{r}{K(\\alpha+r)} \\exp(\\alpha t) + \\left(\\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}\\right) \\exp(-rt)\n$$\nNow we apply the peak condition $N(t_{\\text{peak}}) = K(t_{\\text{peak}})$, or equivalently, $\\frac{1}{N(t_{\\text{peak}})} = \\frac{1}{K(t_{\\text{peak}})}$. Since $K(t) = K \\exp(-\\alpha t)$, we have $\\frac{1}{K(t)} = \\frac{1}{K} \\exp(\\alpha t)$. Let $t = t_{\\text{peak}}$:\n$$\n\\frac{r}{K(\\alpha+r)} \\exp(\\alpha t_{\\text{peak}}) + \\left(\\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}\\right) \\exp(-rt_{\\text{peak}}) = \\frac{1}{K} \\exp(\\alpha t_{\\text{peak}})\n$$\nWe rearrange this equation to solve for $t_{\\text{peak}}$. Group terms with $\\exp(\\alpha t_{\\text{peak}})$:\n$$\n\\left(\\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}\\right) \\exp(-rt_{\\text{peak}}) = \\left(\\frac{1}{K} - \\frac{r}{K(\\alpha+r)}\\right) \\exp(\\alpha t_{\\text{peak}})\n$$\nSimplify the coefficient on the right-hand side:\n$$\n\\frac{1}{K} - \\frac{r}{K(\\alpha+r)} = \\frac{\\alpha+r-r}{K(\\alpha+r)} = \\frac{\\alpha}{K(\\alpha+r)}\n$$\nThe equation becomes:\n$$\n\\left(\\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}\\right) \\exp(-rt_{\\text{peak}}) = \\frac{\\alpha}{K(\\alpha+r)} \\exp(\\alpha t_{\\text{peak}})\n$$\nIsolate the exponential terms:\n$$\n\\frac{\\exp(\\alpha t_{\\text{peak}})}{\\exp(-rt_{\\text{peak}})} = \\exp((\\alpha+r)t_{\\text{peak}}) = \\frac{\\frac{1}{N_0} - \\frac{r}{K(\\alpha+r)}}{\\frac{\\alpha}{K(\\alpha+r)}}\n$$\nMultiplying the numerator and denominator of the right-hand side by $K(\\alpha+r)$ gives:\n$$\n\\exp((\\alpha+r)t_{\\text{peak}}) = \\frac{K(\\alpha+r)}{N_0 \\alpha} - \\frac{r}{\\alpha} = \\frac{K(\\alpha+r) - rN_0}{\\alpha N_0}\n$$\nThis can be rewritten more clearly by rearranging the terms:\n$$\n\\exp((\\alpha+r)t_{\\text{peak}}) = \\frac{K\\alpha + Kr - rN_0}{\\alpha N_0} = \\frac{K\\alpha + r(K - N_0)}{\\alpha N_0} = \\frac{K}{N_0} + \\frac{r}{\\alpha}\\left(\\frac{K}{N_0} - 1\\right)\n$$\nSince $K>N_0$, $r>0$, and $\\alpha>0$, the argument of the expression is greater than $1$, ensuring that $t_{\\text{peak}}$ will be positive. We now take the natural logarithm of both sides:\n$$\n(\\alpha+r)t_{\\text{peak}} = \\ln\\left( \\frac{K}{N_0} + \\frac{r}{\\alpha}\\left(\\frac{K}{N_0} - 1\\right) \\right)\n$$\nFinally, the closed-form analytic expression for $t_{\\text{peak}}$ is:\n$$\nt_{\\text{peak}} = \\frac{1}{\\alpha+r} \\ln\\left( \\frac{K}{N_0} + \\frac{r}{\\alpha}\\left(\\frac{K}{N_0} - 1\\right) \\right)\n$$\nThe units of $t_{\\text{peak}}$ are determined by the units of $r$ and $\\alpha$. The problem implies consistency, so if $r$ and $\\alpha$ are in units of days$^{-1}$, $t_{\\text{peak}}$ will be in days.", "answer": "$$\n\\boxed{\\frac{1}{r+\\alpha} \\ln\\left(\\frac{K}{N_0} + \\frac{r}{\\alpha}\\left(\\frac{K}{N_0} - 1\\right)\\right)}\n$$", "id": "2831575"}]}